Literature DB >> 8859005

Disposition of oligonucleotides in isolated perfused rat kidney: involvement of scavenger receptors in their renal uptake.

K Sawai1, R I Mahato, Y Oka, Y Takakura, M Hashida.   

Abstract

The objective of this study was to clarify the renal disposition characteristics of a 20-mer model phosphodiester oligonucleotide and its partially (PS3) and fully (PS) phosphorothioated derivatives, in isolated rat perfused kidney. Venous outflow and urinary excretion pattern, as well as tissue accumulation of radioactivity after bolus injection of 32P-labeled oligonucleotides, were evaluated under both filtering and nonfiltering conditions. The binding affinity of oligonucleotides to bovine serum albumin in the perfusate increased as the number of sulfur atoms present in the oligonucleotide molecules increased, resulting in 21, 60 and 86% binding to bovine serum albumin for phosphodiester oligonucleotide, PS3 and PS, respectively. The apparent steady-state distribution volumes of the oligonucleotides, as calculated from the venous outflow patterns, were larger than that of inulin, which corresponds to the extracellular volume of the kidney, suggesting their interaction with tissue from the vascular space. PS showed the largest distribution volume. Urinary excretion of oligonucleotides was greatly restricted, compared with that of inulin, which was used as a marker of glomerular filtration rate. The accumulation of these oligonucleotides was ascribed to both tubular reabsorption and uptake from the capillary side. The uptake of oligonucleotides from the capillary side increased as the number of sulfur atoms present in the molecules increased, suggesting sulfur atom-dependent interactions between oligonucleotides and renal tissue. In addition, the uptake of PS3 was a saturable process. Furthermore, coadministration of dextran sulfate and polyinosinic acid inhibited the renal uptake of PS3, whereas polycytidic acid and 4-acetamido-4'-isothiocyanato-stilbene-2,2'-disulfonic acid did not, suggesting that oligonucleotides were taken up via the scavenger receptor-mediated process for polyanions. These findings provide valuable information for the development of delivery systems for antisense oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8859005

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  The influence of base sequence on the immunostimulatory properties of DNA.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Metabolism of GTI-2040, a phosphorothioate oligonucleotide antisense, using ion-pair reversed phase high performance liquid chromatography (HPLC) coupled with electrospray ion-trap mass spectrometry.

Authors:  Xiaohui Wei; Guowei Dai; Zhongfa Liu; Hao Cheng; Zhiliang Xie; Guido Marcucci; Kenneth K Chan
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

Review 3.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

4.  The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides.

Authors:  F G Zhu; C F Reich; D S Pisetsky
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

5.  In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells.

Authors:  M K Bijsterbosch; M Manoharan; E T Rump; R L De Vrueh; R van Veghel; K L Tivel; E A Biessen; C F Bennett; P D Cook; T J van Berkel
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

6.  Receptor-mediated hepatic uptake of M6P-BSA-conjugated triplex-forming oligonucleotides in rats.

Authors:  Zhaoyang Ye; Kun Cheng; Ramareddy V Guntaka; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

Review 7.  Biological barriers to therapy with antisense and siRNA oligonucleotides.

Authors:  R Juliano; J Bauman; H Kang; X Ming
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

8.  HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.

Authors:  Ningning Yang; Zhaoyang Ye; Feng Li; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2009-02       Impact factor: 4.774

9.  Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.

Authors:  Shan Gao; San Hein; Frederik Dagnæs-Hansen; Kathrin Weyer; Chuanxu Yang; Rikke Nielsen; Erik I Christensen; Robert A Fenton; Jørgen Kjems
Journal:  Theranostics       Date:  2014-08-13       Impact factor: 11.556

10.  Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.

Authors:  Diana Rubel; Joseph Boulanger; Florin Craciun; Ethan Y Xu; Yanqin Zhang; Lucy Phillips; Michelle Callahan; William Weber; Wenping Song; Nicholas Ngai; Nikolay O Bukanov; Xingyi Shi; Ali Hariri; Hervé Husson; Oxana Ibraghimov-Beskrovnaya; Shiguang Liu; Oliver Gross
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.